Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 19Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 5Leukemia 5Hemangioma 5Lymphoma, Large-Cell, Anaplastic 4Prostatic Neoplasms 3Neoplasms 3Lymphoma, B-Cell 3Immunoblastic Lymphadenopathy 3Neurotoxicity Syndromes 2Neoplasm, Residual 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Stenosis 2Enteropathy-Associated T-Cell Lymphoma 2Vomiting 1Thymoma 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Polycystic Ovary Syndrome 1Philadelphia Chromosome 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Nausea 1

Interventions

Echocardiography 14Doxorubicin 10Exercise 8Electrocardiography 7Trastuzumab 6Cyclophosphamide 5Carvedilol 5Docetaxel 3Atorvastatin 3salicylhydroxamic acid 2sacubitril and valsartan sodium hydrate drug combination 2empagliflozin 2dapagliflozin 2Tablets 2Social Determinants of Health 2Silymarin 2Magnetic Resonance Spectroscopy 2Ivabradine 2High-Intensity Interval Training 2Exercise Test 2Chemoradiotherapy 2Blood Specimen Collection 2Bisoprolol 2Antineoplastic Agents 2Anthracyclines 2sulforaphane 1schizandrin 1pegfilgrastim 1nicotinamide-beta-riboside 1mitoquinone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cardiotoxicity × Prednisolone × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡